Severity: Warning
Message: file_get_contents(https://...@gmail.com&api_key=61f08fa0b96a73de8c900d749fcb997acc09&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
Filename: helpers/my_audit_helper.php
Line Number: 197
Backtrace:
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 197
Function: file_get_contents
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 271
Function: simplexml_load_file_from_url
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3165
Function: getPubMedXML
File: /var/www/html/application/controllers/Detail.php
Line: 597
Function: pubMedSearch_Global
File: /var/www/html/application/controllers/Detail.php
Line: 511
Function: pubMedGetRelatedKeyword
File: /var/www/html/index.php
Line: 317
Function: require_once
98%
921
2 minutes
20
Pulmonary neuroendocrine tumors (pNETs) have distinct pathologic characteristics. Typical carcinoids are indolent neoplasms with a good prognosis, whereas atypical carcinoids have a less indolent behavior. Both are optimally treated with complete surgical excision. More aggressive pNETs often present with local invasion, thoracic lymph nodal metastases, and distant spread. Patients may not be candidates for surgical resection and are treated with chemotherapy and/or radiation therapy. This article examines the potential role of functional imaging evaluation using (18)F FDG and somatostatin analogues labeled with (68)Ga DOTA-peptides in well-differentiated pNETs with particular attention to clinical and surgical implications.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.thorsurg.2014.04.004 | DOI Listing |